Vaccinia virus expressing MIC8 and AMA1 provides protection against Toxoplasma gondii ME49 infection
Open Access
- 19 November 2025
- journal article
- Published by Korean Society for Parasitology in Parasites, Hosts and Diseases
- Vol. 63 (4) , 340-348
Abstract
Toxoplasma gondii is an intracellular protozoan parasite capable of causing chronic infection by forming persistent cysts in the brain. Despite its global burden, no approved vaccine exists. Virus-like particle vaccines expressing microneme protein 8 (MIC8) or apical membrane antigen 1 (AMA1) of T. gondii have previously shown efficacy. In this study, we generated recombinant vaccinia viruses (rVVs) expressing MIC8 and AMA1 and evaluated their efficacy against T. gondii ME49 infection. BALB/c mice were intramuscularly immunized with a combination of MIC8 and AMA1 rVVs and challenged orally with T. gondii ME49. Immunization with MIC8+AMA1 rVVs produced a significant increase in T. gondii-specific IgG. Splenocyte analysis revealed robust activation of CD4+ and CD8+ T cells, as well as expansion of memory B cells. The immunized group exhibited an 89.6% reduction in brain cyst count, with significantly improved survival compared to the control group. These findings demonstrate that combining the antigens MIC8 and AMA1 using a vaccinia virus platform can effectively promote both humoral and cellular immunity, supporting its potential as a vaccine strategy against T. gondii ME49.Keywords
Funding Information
- National Research Foundation of Korea (2018-R1A6A1A03025124)
- Ministry of Education
This publication has 20 references indexed in Scilit:
- Protection induced by recombinant vaccinia virus targeting the ROP4 of Toxoplasma gondii in miceExperimental Parasitology, 2025
- Protective humoral immunity induced by virus-like particles expressing Toxoplasma gondii CST1 or MIC8Acta Tropica, 2024
- Invasion of Toxoplasma gondii bradyzoites: Molecular dissection of the moving junction proteins and effective vaccination targetsProceedings of the National Academy of Sciences, 2023
- The molecular biology and immune control of chronic Toxoplasma gondii infectionJournal of Clinical Investigation, 2020
- Virus-like particle vaccine displaying Toxoplasma gondii apical membrane antigen 1 induces protection against T. gondii ME49 infection in miceMicrobial Pathogenesis, 2020
- Virus-like particles containing multiple antigenic proteins of Toxoplasma gondii induce memory T cell and B cell responsesPLOS ONE, 2019
- Toxoplasma gondii microneme protein 8 (MIC8) is a potential vaccine candidate against toxoplasmosisParasitology Research, 2010
- A heterologous prime-boost vaccination regime using DNA and a vaccinia virus, both expressing GRA4, induced protective immunity againstToxoplasma gondiiinfection in miceParasitology, 2007
- MVA ROP2 vaccinia virus recombinant as a vaccine candidate for toxoplasmosisParasitology, 2004
- Structures of Toxoplasma gondii Tachyzoites, Bradyzoites, and Sporozoites and Biology and Development of Tissue CystsClinical Microbiology Reviews, 1998